Ethic Inc. Repligen Corp Transaction History

Ethic Inc.

$4.8 Billion
Q1 2025

A detailed history of Ethic Inc. transactions in Repligen Corp stock. As of the latest transaction made, Ethic Inc. holds 5,065 shares of RGEN stock, worth $612,915. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,065

Previous 1,712 195.85%

Holding current value

$612,915

Previous $246,000 161.79%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$127.24 - $174.24 $426,635 - $584,226	3,353 Added 195.85%	5,065 $644,000
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $6,047 - $7,885	49 Added 2.95%	1,712 $246,000
Q3 2024 Nov 13, 2024	BUY	$119.79 - $167.35 $199,210 - $278,303	1,663 New	1,663 $247,000
Q1 2024 May 13, 2024	SELL	$170.78 - $208.42 $2,732 - $3,334	-16 Reduced 0.95%	1,663 $305,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $20,436 - $33,177	179 Added 11.93%	1,679 $301,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $98,117 - $124,792	-707 Reduced 32.03%	1,500 $238,000
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $78,068 - $101,694	-564 Reduced 20.35%	2,207 $312,000
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $5,090 - $6,537	33 Added 1.21%	2,771 $466,000
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $70,327 - $95,502	-433 Reduced 13.65%	2,738 $463,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $123,202 - $196,769	768 Added 31.96%	3,171 $593,000
Q2 2022 Aug 10, 2022	SELL	$140.68 - $188.02 $21,946 - $29,331	-156 Reduced 6.1%	2,403 $390,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $97,842 - $156,581	607 Added 31.1%	2,559 $481,000
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $17,826 - $21,921	72 Added 3.83%	1,952 $517,000
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $92,126 - $153,351	473 Added 33.62%	1,880 $543,000
Q2 2021 Aug 10, 2021	BUY	$165.87 - $220.95 $233,379 - $310,876	1,407 New	1,407 $281,000

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.71B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account